Alternative translation initiation of Caveolin-2 desensitizes insulin signaling through dephosphorylation of insulin receptor by PTP1B and causes insulin Check for resistanceopen access
- Authors
- Kwon, Hayeong; Jang, Donghwan; Choi, Moonjeong; Lee, Jaewoong; Jeong, Kyuho; Pak, Yunbae
- Issue Date
- Jun-2018
- Publisher
- ELSEVIER SCIENCE BV
- Keywords
- Caveolin-2; Alternative translation initiation; Insulin receptor; Protein tyrosine phosphatase 1B; Lysosomal degradation; Insulin resistance
- Citation
- BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, v.1864, no.6, pp 2169 - 2182
- Pages
- 14
- Indexed
- SCI
SCIE
SCOPUS
- Journal Title
- BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Volume
- 1864
- Number
- 6
- Start Page
- 2169
- End Page
- 2182
- URI
- https://scholarworks.gnu.ac.kr/handle/sw.gnu/11620
- DOI
- 10.1016/j.bbadis.2018.03.022
- ISSN
- 0925-4439
1879-260X
- Abstract
- Insulin resistance, defined as attenuated sensitivity responding to insulin, impairs insulin action. Direct causes and molecular mechanisms of insulin resistance have thus far remained elusive. Here we show that alternative translation initiation (ATI) of Caveolin-2 (Cav-2) regulates insulin sensitivity. Cav-2 beta isoform yielded by ATI desensitizes insulin receptor (IR) via dephosphorylation by protein-tyrosine phosphatase 1B (PTP1B), and subsequent endocytosis and lysosomal degradation of IR, causing insulin resistance. Blockage of Cav-2 ATI protects against insulin resistance by preventing Cav-2 beta-PTP1B-directed IR desensitization, thereby normalizing insulin sensitivity and glucose uptake. Our findings show that Cav-2 beta is a negative regulator of IR signaling, and identify a mechanism causing insulin resistance through control of insulin sensitivity via Cav-2 ATI.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - ETC > Journal Articles

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.